SYK Stock - Stryker Corp.

SYK Stock Chart

SYK Profile

Stryker Corporation, a leading medical technology company, operates through two primary segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment offers a range of implants for hip and knee joint replacements, as well as products for trauma and extremities surgeries. This segment also includes spinal implant products such as cervical, thoracolumbar, and interbody systems, which are utilized in therapies for spinal injury, deformity, and degenerative conditions.

The MedSurg and Neurotechnology segment encompasses a wide array of surgical equipment and navigation systems, endoscopic and communication systems, patient handling and emergency medical equipment, and intensive care disposable products. It also provides reprocessed and remanufactured medical devices. Additionally, this segment includes neurotechnology products designed for minimally invasive endovascular techniques, brain and open skull-based surgical procedures, orthobiologic and biosurgery products such as synthetic bone grafts and vertebral augmentation products, and devices for treating acute ischemic and hemorrhagic stroke. The segment also offers craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants.

Stryker Corporation distributes its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors across approximately 75 countries. Founded in 1941 and headquartered in Kalamazoo, Michigan, Stryker continues to innovate and expand its portfolio to meet the evolving needs of the medical field, ensuring a global presence in the healthcare industry.

SYK Revenue Chart

SYK Earnings

Analyst Ratings